The source of nicotinamide riboside (NR) is a critical safety issue, as the material used in clinical testing may differ from commercially available products. — Whalespan
The source of nicotinamide riboside (NR) is a critical safety issue, as the material used in clinical testing may differ from commercially available products.
⚠ High risk
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
◐PARTIALLYSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“Sourcing is probably the biggest safety issue, right? Because if the material is the same material that has been clinically tested, then you have some, you know, basis for feeling that you can take it as a as a human, right? Um, if it just has the same chemical name, like if it's you read some study about NMN being done in a hospital in Boston or Tokyo or something like that and then you go on Amazon and you buy NN, you're probably not using the same material that was tested in that hospital, right? And there's really no telling what's in it. So I think that um the source is really really important in terms of what people are taking.”